Highly differentiated interventional cryosurgical system technology
CE Mark and NMPA approval
Commercialization from China to the world
Serving for over 100 hospitals
RCT study shows non-inferiority of cryoablation in NSCLC with 81 patients
Manufacturing process includes ISO13485 and a QMS system for global supply
200+ employees, 30% R&D personnels
The members of the R&D team hold degrees from prestigious universities like Tsinghua University, Peking Union Medical College, Chinese Academy of Sciences, etc.
Sufficient spare parts
Technical support
Concrete operation training
Hygea Medical Technology Co., Ltd.
Hygea Medical Technology Co., Ltd.
EN 
